Teladoc Health Inc (TDOC)

Overview News Price History Option Chain Discussions Forecast

Teladoc Health Inc stock is currently priced at $13.74, with a 24-hour trading volume of 3.93M. It has seen a +3.31% increased in the last 24 hours and a -8.40% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $13.24 pivot point. If it approaches the $13.79 resistance level, significant changes may occur.

Teladoc Health Inc Stock (TDOC) Financials Data

Teladoc Health Inc (TDOC) Revenue 2024

TDOC reported a revenue (TTM) of $2.60 billion for the quarter ending December 31, 2023, a +8.13% rise year-over-year.

Teladoc Health Inc (TDOC) Net Income 2024

TDOC net income (TTM) was -$220.37 million for the quarter ending December 31, 2023, a +98.39% increase year-over-year.

Teladoc Health Inc (TDOC) Cash Flow 2024

TDOC recorded a free cash flow (TTM) of $193.67 million for the quarter ending December 31, 2023, a +1,072% increase year-over-year.

Teladoc Health Inc (TDOC) Earnings per Share 2024

TDOC earnings per share (TTM) was -$1.34 for the quarter ending December 31, 2023, a +98.42% growth year-over-year.

Teladoc Health Inc Stock (TDOC) Latest News

Can Higher Visits Soften Cost Blow for Teladoc (TDOC) in Q1?

Zacks Investment Research

Why Investors Should Choose the Nasdaq-100 Over the Ark Innovation ETF

The Motley Fool

Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week

Benzinga

Should You Buy This Beaten-Down Stock?

The Motley Fool

Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2024 Update

Seeking Alpha

Analysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out for

Zacks Investment Research

Teladoc Health, Inc. provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone. It serves employers of Fortune 1000 companies, health plans, health systems, and other entities. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was founded in 2002 and is headquartered in Purchase, New York.

Downgrade	DA Davidson: Buy → Neutral	Jan-17-24
Initiated	Barclays: Overweight	Jan-03-24
Initiated	Stephens: Equal-Weight	Apr-12-23
Upgrade	SVB Securities: Market Perform → Outperform	Feb-23-23
Upgrade	Guggenheim: Sell → Neutral	Oct-24-22
Initiated	KeyBanc Capital Markets: Sector Weight	Sep-16-22
Initiated	Truist: Hold	Sep-07-22
Downgrade	Guggenheim: Neutral → Sell	Aug-17-22
Initiated	DA Davidson: Buy	Aug-12-22
Downgrade	Berenberg: Buy → Hold	Aug-02-22
Downgrade	Cowen: Outperform → Market Perform	Aug-02-22
Downgrade	Goldman: Buy → Neutral	Jul-28-22
Downgrade	Needham: Buy → Hold	Jul-28-22
Reiterated	BofA Securities: Neutral	Jul-06-22
Downgrade	Argus: Buy → Hold	May-05-22
Downgrade	Citigroup: Buy → Neutral	Apr-28-22
Downgrade	Credit Suisse: Outperform → Neutral	Apr-28-22
Downgrade	Guggenheim: Buy → Neutral	Apr-28-22
Downgrade	JP Morgan: Overweight → Neutral	Apr-28-22
Downgrade	SVB Leerink: Outperform → Mkt Perform	Apr-28-22
Downgrade	Wells Fargo: Overweight → Equal Weight	Apr-28-22
Downgrade	William Blair: Outperform → Mkt Perform	Apr-28-22
Initiated	Guggenheim: Buy	Apr-07-22
Resumed	Credit Suisse: Outperform	Apr-01-22
Upgrade	Argus: Hold → Buy	Mar-03-22
Reiterated	BofA Securities: Neutral	Feb-23-22
Reiterated	Craig Hallum: Hold	Feb-23-22
Reiterated	Evercore ISI: In-line	Feb-23-22
Reiterated	Goldman: Buy	Feb-23-22
Reiterated	JP Morgan: Overweight	Feb-23-22
Reiterated	KeyBanc Capital Markets: Overweight	Feb-23-22
Reiterated	Needham: Buy	Feb-23-22
Reiterated	Oppenheimer: Outperform	Feb-23-22
Reiterated	Stifel: Hold	Feb-23-22
Initiated	Goldman: Buy	Feb-11-22
Reiterated	Piper Sandler: Overweight	Feb-08-22
Resumed	Jefferies: Hold	Dec-02-21
Downgrade	BTIG Research: Buy → Neutral	Nov-22-21
Reiterated	Barclays: Equal Weight	Oct-28-21
Reiterated	BofA Securities: Neutral	Oct-28-21
Reiterated	Canaccord Genuity: Buy	Oct-28-21
Reiterated	Citigroup: Buy	Oct-28-21
Reiterated	Craig Hallum: Hold	Oct-28-21
Reiterated	Needham: Buy	Oct-28-21
Reiterated	Oppenheimer: Outperform	Oct-28-21
Reiterated	Piper Sandler: Overweight	Oct-28-21
Reiterated	UBS: Neutral	Oct-28-21
Initiated	Wells Fargo: Overweight	Oct-19-21
Downgrade	Argus: Buy → Hold	Aug-02-21
Downgrade	Deutsche Bank: Buy → Hold	Jul-28-21
Initiated	Robert W. Baird: Neutral	May-28-21
Initiated	Needham: Buy	Apr-15-21
Initiated	BTIG Research: Buy	Jan-07-21
Initiated	Evercore ISI: In-line	Dec-22-20
Downgrade	Stephens: Overweight → Equal-Weight	Dec-07-20
Initiated	Goldman: Neutral	Dec-04-20
Upgrade	Robert W. Baird: Neutral → Outperform	Nov-13-20
Initiated	DA Davidson: Buy	Sep-22-20
Upgrade	Berenberg: Hold → Buy	Sep-02-20
Upgrade	Credit Suisse: Neutral → Outperform	Aug-17-20
Initiated	Citigroup: Buy	Jul-14-20
Initiated	Argus: Buy	Jul-13-20
Initiated	Stephens: Overweight	Jul-07-20
Reiterated	KeyBanc Capital Markets: Overweight	Apr-30-20
Initiated	SVB Leerink: Outperform	Apr-13-20
Downgrade	Berenberg: Buy → Hold	Mar-31-20
Downgrade	Craig Hallum: Buy → Hold	Mar-25-20
Upgrade	KeyBanc Capital Markets: Sector Weight → Overweight	Mar-16-20
Downgrade	Robert W. Baird: Outperform → Neutral	Mar-12-20
Downgrade	KeyBanc Capital Markets: Overweight → Sector Weight	Feb-28-20
Downgrade	Wells Fargo: Overweight → Equal Weight	Feb-12-20
Initiated	UBS: Neutral	Jan-10-20
Downgrade	BofA/Merrill: Buy → Neutral	Jan-09-20